Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 04, 2026 08:00 ET | Source: Normunity

Normunity to Participate in the TD Cowen 46ᵗʰ Annual Health Care Conference

BOSTON and NEW HAVEN, Conn., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Normunity, a clinical stage biotechnology company pioneering precision biologics, today announced that management will participate in...
November 05, 2025 08:30 ET | Source: Normunity

Normunity announces first patient dosed in Phase 1 clinical study of NRM-823, a T Cell Engager against a novel tumor-specific target, in patients with solid tumors

Phase 1a/1b study will evaluate NRM-823 as monotherapy and in combination with immune checkpoint inhibition in patients with locally-advanced or metastatic refractory solid tumors NRM-823 is a T cell...